Preexposure Prophylaxis for Prevention of HIV Acquisition Among Adolescents: Clinical Considerations, 2020

Preexposure prophylaxis (PrEP) with antiretroviral medication has been proven effective in reducing the risk for acquiring human immunodeficiency virus (HIV). The fixed-dose combination tablet of tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC) was approved by the U.S. Food and Drug Administr...

Полное описание

Библиографические подробности
Главные авторы: Tanner, Mary R., Miele, Peter, Carter, Wendy, Valentine, Sheila Salvant, Dunville, Richard, Kapogiannis, Bill G., Smith, Dawn K.
Формат: Online Статья Текст
Язык:English
Опубликовано: Centers for Disease Control and Prevention 2020
Предметы:
Recommendations and Reports
Online-ссылка:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188407/
https://www.ncbi.nlm.nih.gov/pubmed/32324724
http://dx.doi.org/10.15585/mmwr.rr6903a1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188407/
https://www.ncbi.nlm.nih.gov/pubmed/32324724
http://dx.doi.org/10.15585/mmwr.rr6903a1

Схожие документы